Evidence map›Paper›PMID 39227808›Full record

ArticleBMC cancer2024

Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells.

Emad Dabous, Mai Alalem, Ahmed M Awad, Khaled A Elawdan, Ahmed M Tabl, Shorouk Elsaka, Walid Said, Adel A Guirgis, Hany Khalil

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Epigallocatechin-3-gallate inhibits replication of influenza A virus via restoring the host methylated genes following infection.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emad DabousDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Mai AlalemDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Ahmed M AwadDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Khaled A ElawdanDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Ahmed M TablDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Shorouk ElsakaDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Walid SaidMicrobiology and Chemistry Department, Faculty of Science, Benha University, Benha, Egypt.
Adel A GuirgisDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt.
Hany KhalilDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, P.O Box 79, Sadat City, Egypt. hany.khalil@gebri.usc.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMicroRNAs (miRNAs) are single RNA molecules that act as global regulators of gene expression in mammalian cells and thus constitute attractive targets in treating cancer. Here we aimed to investigate the possible involvement of miRNA-141 (miR-141) in cervical cancer and to identify its potential targets in cervical cancer cell lines.

methodsThe level of miR-141 in HeLa and C-33A cells has been assessed using the quantitative real-time PCR (qRT-PCR). A new miR-141 construct has been performed in a CMV promoter vector tagged with GFP. Using microarray analysis, we identified the potentially regulated genes by miR-141 in transfected HeLa cells. The protein profile of killer-like receptor C1 (KLRC1), KLRC3, carcinoembryonic antigen-related cell adhesion molecule 3 (CAM3), and CAM6 was investigated in HeLa cells transfected with either an inhibitor, antagonist miR-141, or miR-141 overexpression vector using immunoblotting and flow cytometry assay. Finally, ELISA assay has been used to monitor the produced cytokines from transfected HeLa cells.

resultsThe expression of miR-141 significantly increased in HeLa and C-33A cells compared to the normal cervical HCK1T cell line. Transfection of HeLa cells with an inhibitor, antagonist miR-141, showed a potent effect on cancer cell viability, unlike the transfection of miR-141 overexpression vector. The microarray data of HeLa cells overexpressed miR-141 provided a hundred of downregulated genes, including KLRC1, KLRC3, CAM3, and CAM6. KLRC1 and KLRC3 expression profiles markedly depleted in HeLa cells transfected with miR-141 overexpression accompanied by decreasing interleukin 8 (IL-8), indicating the role of miR-141 in avoiding programmed cells death in HeLa cells. Likewise, CAM3 and CAM6 expression reduced markedly in miR-141 transduced cells accompanied by an increasing level of transforming growth factor beta (TGF-β), indicating the impact of miR-141 in cancer cell migration. The IntaRNA program and miRWalk were used to check the direct interaction and potential binding sites between miR-141 and identified genes. Based on this, the seeding regions of each potential target was cloned upstream of the luciferase reporter gene in the pGL3 control vector. Interestingly, the luciferase activities of constructed vectors were significantly decreased in HeLa cells pre-transfected with miR-141 overexpression vector, while increasing enormously in cells pre-transfected with miR-141 specific inhibitor.

conclusionTogether, these data uncover an efficient miR-141-based mechanism that supports cervical cancer progression and identifies miR-141 as a credible therapeutic target.

Indexed as

Antigens, CDCell Adhesion MoleculesCell ProliferationGene Expression Regulation, NeoplasticMicroRNAsUterine Cervical NeoplasmsCell Line, TumorCell MovementFemaleHeLa CellsHumansNeoplasm MetastasisReceptors, ImmunologicAntigens, CDCD66 antigensCell Adhesion MoleculesMicroRNAsMIRN141 microRNA, humanReceptors, ImmunologicCeacam genesCell proliferationCervical cancerKLRC genesMetastasisMiR-141

Identifiers

PMID39227808
PMCPMC11370040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.